Cravens & Co Advisors »

GSK shares owned by Cravens & Co Advisors

Quarter-by-quarter ownership of GSK (GSK) shares owned by Cravens & Co Advisors from 13F filings

Historical chart of Cravens & Co Advisors investment in GSK

Tip: Access up to 7 years of quarterly data

All positions including GSK held by Cravens & Co Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in GSK by Cravens & Co Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $331k 8.9k 37.06
2023-09-30 $335k 9.2k 36.25
2023-06-30 $333k 9.3k 35.64
2023-03-31 $335k 9.4k 35.58
2022-12-31 $331k 9.4k 35.14

More positions owned by Cravens & Co Advisors

Smartfinancial Com New (SMBK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Doubleline Etf Trust Opportunistic Bd (DBND)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Dimensional Etf Trust Intl Core Equity (DFIC)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Us Small Cap Val (DFSV)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Chevron Corporation (CVX)
Boeing Company (BA)
Netflix (NFLX)

View all positions for Cravens & Co Advisors

Top funds holding GSK

Dodge & Cox
FMR
JTC Employer Solutions Trustee
Fisher Investments
Morgan Stanley
PRIMECAP Management Company
T. Rowe Price Associates
Holocene Advisors
Royal Bank of Canada
Mondrian Investment Partners
Goldman Sachs Group
Provident Trust
Equity Investment Corp Acquisition
Hotchkis and Wiley Capital Management
Hsbc Holdings

View all funds holding GSK